#2887 Global Rank Marché Ouvert

Subbamma Jasti

Santé & Biotech. Pharmaceuticals.

Fortune Nette (Est.)

$1.3 B
+$493 (+0.00%) Aujourd'hui
Portefeuille : Suven Life Sciences ▲ High Growth Suven Pharmaceuticals ▲ High Growth
Subbamma Jasti

Photo: Press Agency / 2026

Profil Financier

Subbamma Jasti occupe actuellement le rang #2887 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.3 B (+$493 sur 24h).

Subbamma Jasti inherited the assets of her husband Subba Rao Jasti, who died in 2023.

The biggest chunk of her inheritance is derived from the sale of a substantial stake in listed Suven Pharmaceuticals in 2022 to global private equity firm Advent International.

Jasti's son Venkateswarlu Jasti cofounded Suven Pharmaceuticals in 1989.

The Hyderabad company was demerged in 2020 when Suven Life Sciences, which focuses on neuroscience therapies, was spun off and listed separately.

Her son Venkateswarlu Jasti ran a chain six of community pharmacies in the states of New York and New Jersey in the U.S. in the 1970s and 1980s.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
Suven Life Sciences (530239-IN) 153.2M parts $491 M High Growth
Suven Pharmaceuticals (543064-IN) 25.1M parts $118 M High Growth